WEEKEND UPDATE
September 12, 2020
Dear Valued Reader,

Happy Weekend, dear friend -- did you miss anything Gumshoe-y in the week that was?  Just stick with me for a moment, and we'll catch you up...
We started out with a refreshed look at Tom Gardner's "Double Down" stock for Motley Fool Stock Advisor... is it the same one he's been pitching for a couple years? (um, yeah)... is it still worth considering here?  Just click below to...


Advertisement

Then we moved up North, looking into a tease from the Motley Fool Canada -- they're talking up a small company that's "following in Shopify's footsteps," our story on that one is here.

And Michael Jorrin popped in with a Doc Gumshoe update for us, this time explaining some of the developments in COVID testing (among other things) -- click here for that one.

I also took a second look at a couple of other heavily-teased pitches this week -- the first was Dave Lashmet's anti-obesity drug being touted by Stansberry, since that ad generated a lot of new questions this week, and you can see the Thinkolator results on that obesity one here.

And the other longer-running pitch that drove a lot of questions our way this week is Paul Mampilly's "12 million mile battery", so you can see that one here if you missed it the first time around.

Then it was time for the Friday File, when I provided a few Real Money Portfolio updates and also some thoughts on "Pre-IPO" pitches (biotech and airbnb) from a couple different publishers -- if you missed that email on Friday, just click below...



Stock Gumshoe | travis@stockgumshoe.com | www.stockgumshoe.com
351 Pleasant St., Suite B #205, Northampton, MA 01060
Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

Having trouble viewing this email? Read the web version.

You may unsubscribe if you no longer wish to receive our emails. We have no wish to email people who don't want to receive these messages. Please note that unsubscribing applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.